Xiao‐Chen Zhang

777 total citations
32 papers, 624 citations indexed

About

Xiao‐Chen Zhang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Xiao‐Chen Zhang has authored 32 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Xiao‐Chen Zhang's work include Catalytic C–H Functionalization Methods (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and HER2/EGFR in Cancer Research (3 papers). Xiao‐Chen Zhang is often cited by papers focused on Catalytic C–H Functionalization Methods (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and HER2/EGFR in Cancer Research (3 papers). Xiao‐Chen Zhang collaborates with scholars based in China, United States and Singapore. Xiao‐Chen Zhang's co-authors include Tong‐Hao Zhu, Kai Zhao, Teck‐Peng Loh, Nuo Xu, Yuyan Zhu, Yaning Chang, Shaowei Liu, Yingjun Zhou, Zhuo Yang and Yanli Hou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xiao‐Chen Zhang

28 papers receiving 622 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiao‐Chen Zhang 207 140 137 97 66 32 624
Junjie Yang 148 0.7× 89 0.6× 188 1.4× 39 0.4× 32 0.5× 42 564
Martin Berger 92 0.4× 154 1.1× 248 1.8× 99 1.0× 127 1.9× 40 743
Yue Xu 138 0.7× 69 0.5× 305 2.2× 59 0.6× 88 1.3× 35 664
Yongzhi Lu 192 0.9× 128 0.9× 344 2.5× 27 0.3× 39 0.6× 34 765
Rupinder Kaur Gill 459 2.2× 155 1.1× 306 2.2× 41 0.4× 70 1.1× 34 1.0k
Mei Su 171 0.8× 76 0.5× 212 1.5× 36 0.4× 32 0.5× 36 559
Joseph R. Taylor 130 0.6× 118 0.8× 318 2.3× 157 1.6× 217 3.3× 7 802
Lukáš Werner 169 0.8× 51 0.4× 442 3.2× 63 0.6× 52 0.8× 30 735
Chunlei Xu 54 0.3× 66 0.5× 219 1.6× 46 0.5× 58 0.9× 53 748
Won Hoon Jung 209 1.0× 55 0.4× 220 1.6× 93 1.0× 71 1.1× 40 720

Countries citing papers authored by Xiao‐Chen Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Chen Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Chen Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Chen Zhang more than expected).

Fields of papers citing papers by Xiao‐Chen Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Chen Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Chen Zhang. The network helps show where Xiao‐Chen Zhang may publish in the future.

Co-authorship network of co-authors of Xiao‐Chen Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Chen Zhang. A scholar is included among the top collaborators of Xiao‐Chen Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Chen Zhang. Xiao‐Chen Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Xueli, Xiang Li, Guoliang Qiao, et al.. (2025). Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial. Cancer Cell. 43(12). 2259–2267.e2.
2.
Cheng, Ying, Xiao‐Chen Zhang, Jian Liu, et al.. (2024). YL202/BNT326, a HER3-targeted ADC, in patients with locally advanced or metastatic non-small cell lung cancer and breast cancer: Preliminary results from a first-in-human phase I trial.. Journal of Clinical Oncology. 42(16_suppl). 3034–3034. 5 indexed citations
3.
Liu, Xiaoning, et al.. (2022). Sodium houttuyfonate protects against cardiac injury by regulating cardiac energy metabolism in diabetic rats. European Journal of Pharmacology. 932. 175236–175236. 4 indexed citations
4.
Chen, Jing, et al.. (2022). Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes. Frontiers in Immunology. 13. 982033–982033. 4 indexed citations
5.
Yan, Feifei, et al.. (2022). Metastatic urothelial carcinoma harboring ERBB2/3 mutations dramatically respond to chemotherapy plus anti-PD-1 antibody: A case report. World Journal of Clinical Cases. 10(8). 2497–2503. 1 indexed citations
6.
Zhao, Kai, Xiao‐Chen Zhang, Ji‐Yu Tao, et al.. (2020). Regio- and stereoselective C(sp2)–H acylation of enamides with aldehydes via transition-metal-free photoredox catalysis. Green Chemistry. 22(16). 5497–5503. 45 indexed citations
7.
Zhang, Xiao‐Chen, et al.. (2020). Research progress of traditional Chinese medicine in immune response of respiratory mucosa against influenza virus infection. 36(3). 375–381.
8.
9.
Jiang, Qi, Mixue Xie, & Xiao‐Chen Zhang. (2020). Complete response to trastuzumab and chemotherapy in recurrent urothelial bladder carcinoma with HER2 gene amplification: A case report. World Journal of Clinical Cases. 8(3). 594–599. 9 indexed citations
10.
Zhang, Xiao‐Chen, et al.. (2020). Idiopathic adulthood ductopenia with elevated transaminase only: A case report. World Journal of Clinical Cases. 8(24). 6524–6528. 1 indexed citations
11.
Zhang, Maolin, Xiao‐Chen Zhang, Jiaxin Luo, et al.. (2020). Investigate the Odontogenic Differentiation and Dentin–Pulp Tissue Regeneration Potential of Neural Crest Cells. Frontiers in Bioengineering and Biotechnology. 8. 475–475. 23 indexed citations
12.
Su, Qiang, Xiao‐Chen Zhang, Chenguang Zhang, et al.. (2018). Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis. Journal of Immunology Research. 2018. 1–9. 44 indexed citations
13.
Su, Qiang, Xiao‐Chen Zhang, Huairong Zhang, et al.. (2018). The risk of immune-related endocrine disorders associated with anti-PD-1 inhibitors therapy for solid tumors: A systematic review and meta-analysis. International Immunopharmacology. 59. 328–338. 21 indexed citations
14.
Kong, Mei, et al.. (2017). Breast metastasis of gastric signet-ring cell carcinoma. Journal of Zhejiang University SCIENCE B. 18(11). 1026–1030. 11 indexed citations
15.
Wei, Miaomiao, et al.. (2016). Autophagy is involved in regulating VEGF during high-glucose-induced podocyte injury. Molecular BioSystems. 12(7). 2202–2212. 23 indexed citations
16.
Dai, Li, et al.. (2016). Application Effect of Artificial Pneumothorax on Thoracoscopic Thymectomy. 33(14). 76. 1 indexed citations
17.
Zhang, Xiao‐Chen, Hongqiang Yin, Zhigui Li, Tao Zhang, & Zhuo Yang. (2016). Nano-TiO2 induces autophagy to protect against cell death through antioxidative mechanism in podocytes. Cell Biology and Toxicology. 32(6). 513–527. 49 indexed citations
18.
Chen, Jian, Peng Shen, Xiao‐Chen Zhang, et al.. (2014). Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta-analysis of 11 Randomized Clinical Trials. Clinical Therapeutics. 36(8). 1253–1263. 36 indexed citations
19.
Zheng, Yi, Zhenzhen Xu, Xiao‐Chen Zhang, et al.. (2010). Quantitative profiles of the mRNAs of ER-α and its novel variant ER-α36 in breast cancers and matched normal tissues. Journal of Zhejiang University SCIENCE B. 11(2). 144–150. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junjie Yang Breakdown of academic impact, for papers by Martin Berger Breakdown of academic impact, for papers by Yue Xu Breakdown of academic impact, for papers by Yongzhi Lu Breakdown of academic impact, for papers by Rupinder Kaur Gill Breakdown of academic impact, for papers by Mei Su Breakdown of academic impact, for papers by Joseph R. Taylor Breakdown of academic impact, for papers by Lukáš Werner Breakdown of academic impact, for papers by Chunlei Xu Breakdown of academic impact, for papers by Won Hoon Jung
Rankless by CCL
2026